'The Skin Art Clinic' - A Lucknow-Based Cosmetic Dermatology Clinic Catering to Mumbai's Elite
NewsVoir
Mumbai (Maharashtra) [India], June 13: In a recent press conference held in Mumbai, Dr. Nidhi Singh Tandon, the founder of The Skin Art Clinic, discussed how her Lucknow-based clinic is becoming the preferred destination for skincare, not only in Uttar Pradesh but across India. With the cosmetic dermatology industry traditionally dominated by metropolitan cities like Delhi, Mumbai, and Bangalore, The Skin Art Clinic has managed to carve out a significant presence by offering personalized care, ethical practices, and cutting-edge technology.
The press conference, which was attended by several key media personnel and industry experts, highlighted a unique approach to skincare. A recent survey conducted across major cities like Delhi, Mumbai, and Bangalore by 3EA revealed that The Skin Art Clinic has become the top choice for many patients seeking results-driven treatments. Notably, the clinic has gained significant attention from individuals in Mumbai and Delhi, with many now traveling to Lucknow for treatments that are at par with the best global standards.
Dr. Nidhi Singh Tandon shared her vision behind the clinic and why she has been so successful in attracting patients from across the country, "When I started The Skin Art Clinic, my primary goal was to create a place where patients could receive advanced and holistic skincare, combined with the ethical practices of personalized attention and aftercare," Dr. Nidhi Singh Tandon explained during the press conference.
The clinic stands out for its advanced technology, including Morpheus8 RF Microneedling, ResurFX, IPL Therapy, Venus Freeze, HIFU, and regenerative treatments like PDRN, GFC, and Exosomes. Dr. Nidhi Singh Tandon shared that such technologies have been instrumental in setting the clinic apart. The clinic is the first in Uttar Pradesh, excluding Noida, to introduce Morpheus8, a non-invasive treatment that promotes deep skin remodeling.
When asked, "What inspired you to adopt advanced technologies like Morpheus8 in your clinic?", Dr. Nidhi Singh Tandon replied, "I believe that bringing in advanced technologies is essential for delivering the best results for our patients. Morpheus8, for instance, is one of the most effective treatments for skin tightening and rejuvenation. I adopted it because it's proven to give visible results while minimizing downtime, which is important for today's fast-paced lifestyle."
Further, when asked, "How do you ensure a new technology is truly effective and safe for your patients?" Dr. Nidhi Singh Tandon explained, "We conduct thorough in-clinic trials for every new technology we introduce. We rely on global standards and international validation. Every new treatment undergoes rigorous safety checks before being offered to our patients. Our priority is always patient safety and results."
The clinic's approach to skincare goes beyond just surface-level treatments. Dr. Nidhi Singh Tandon emphasizes a holistic approach that takes into account not just the skin but also a patient's lifestyle, nutrition, and emotional well-being. This has resulted in a loyal patient base who appreciate the personalized care and tailored treatment plans.
Dr. Nidhi Singh Tandon said that the clinic has earned a strong reputation, particularly among celebrities, business leaders, and athletes, who see The Skin Art Clinic as their top choice for skincare. These high-profile clients value privacy and exclusivity.
The clinic's 7-day free follow-up policy is one of the standout features, which is rare in the industry. The Skin Art Clinic also boasts the highest Net Promoter Score (NPS), underscoring its strong referral rates and patient loyalty.
With increasing demand from patients across India, particularly from Uttar Pradesh, Mumbai, Bangalore, and Delhi, The Skin Art Clinic is proving that exceptional skincare doesn't have to come from metro cities. Its cutting-edge technology, personalized care, and ethical practices are setting the clinic apart as a leader in cosmetic dermatology in India.
According to a recent survey conducted by 3EA, The Skin Art Clinic achieved an impressive 72% patient satisfaction rate, surpassing top clinics in Mumbai (67%), Bangalore (64%), and Delhi (58%). These insights were revealed by 3EA during the press conference, underscoring the clinic's growing reputation on a national scale.
Dr. Nidhi Singh Tandon and her team's dedication to innovation and patient care continues to make The Skin Art Clinic the top choice for cosmetic dermatology in Uttar Pradesh and a trusted name across India.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hindu
33 minutes ago
- The Hindu
Applications invited for B. ED Special Education- Multiple Disabilities
Applications are invited for a two year course in in Special education – Multiple disabilities offered by Vidya Sagar, a 40-year-old, Chennai-based organisation working with people with disabilities. It is a full time regular course, on completion of which, the graduate can work in a mainstream school or a special school, start their own rehab center, take up Teacher Eligibility Test for government jobs, or do higher studies and get into research. This course is affiliated to the Tamil Nadu Teacher Education University, has the equivalence of General education and is recognised by the Rehabilitation Council of India. To know more, contact 9840035203 or mail hrd@
Time of India
3 hours ago
- Time of India
Axiom-4 astronauts to study insulin behaviour in microgravity, revolutionise diabetes treatment
New Delhi: Indian astronaut Shubhanshu Shukla's Axiom-4 mission to the International Space Station (ISS) is set to offer a ray of hope for diabetics to travel to space, as a UAE-based healthcare provider is conducting an experiment on how glucose behaves in microgravity part of the "Suite Ride" experiment planned by Burjeel Holdings and Axiom Space, some astronauts of the Axiom-4 mission will be wearing continuous glucose monitors during their 14-day stay on board the orbital lab. The studies of the behaviour of glucose and insulin in microgravity conditions will help scientists develop wearable technologies for astronauts and patients who are bedridden or have limited mobility due to illnesses such as paralysis. "We are trying just to see if there is any change or fluctuation to the blood-sugar levels while they are in space," Mohammad Fityan, chief medical officer at Burjeel Holdings, Abu Dhabi, told PTI. The astronauts will also carry insulin pens in refrigerated and ambient temperatures to examine how the molecules respond to microgravity conditions. "We are hoping that if we learn something about the metabolism or the effect, we will bring some information and we can do something for our patients on Earth," Fityan said. Currently, the National Aeronautics and Space Administration (NASA) does not allow insulin-dependent diabetics to travel to space. There are no official exclusions for non-insulin-dependent diabetics, but so far, no astronaut with diabetes has travelled to space. "It has the potential to transform the future of space travel for astronauts with insulin-dependent diabetes mellitus (IDDM), a condition historically considered disqualifying for space missions," Fityan said. He said the study will pave the way for several innovative technologies and treatment approaches for developing advanced glucose-monitoring tools optimised for extreme or low-activity environments, improving wearable tech for both astronauts and patients with limited mobility on Earth. It will also help identify new pharmacologic targets by observing how metabolic and hormonal responses change in microgravity, leading to drugs that enhance insulin sensitivity or mimic the benefits of exercise in sedentary individuals. The AI-powered predictive models based on real-time physiologic data in space can be adapted to personalise diabetes care on Earth by forecasting insulin needs or metabolic shifts with higher accuracy. The research will also help develop remote monitoring platforms for continuous metabolic-data capture that could revolutionise diabetes care in underserved or remote areas on Earth as well as in tele-health settings.
Time of India
4 hours ago
- Time of India
Major chocolate recall sweeps U.S stores — here's why your favorite sweet treat might be unsafe
Weaver Nut Company is recalling certain semi-sweet chocolate nonpareils distributed throughout the United States. If you recently purchased semi-sweet chocolate nonpareils from a grocery or retail store, you should double-check the lot number. Major chocolate recall sweeps U.S. stores: The U.S. Food and Drug Administration (FDA) announced in a news release on Wednesday that Weaver Nut Company was recalling its semi-sweet chocolate nonpareils with white or Christmas-colored seeds, with particular lot codes, due to possible unreported milk allergies, as per a report by Newsweek. Although no illnesses have been reported, people who are allergic to milk face a serious risk. The chocolates were sold through supermarkets and retail stores throughout the United States. ALSO READ: McDonald's boycott June 24: Who's behind it, why it's happening, and how long it will last Why is your favourite sweet treat unsafe? According to the FDA's release, the problem was discovered after a wholesale customer complained about differences in product specifications. Live Events The chocolates were labelled as being free of milk, but later laboratory testing revealed that they did contain milk proteins, it added. It further stated that consuming the affected items could result in severe or fatal allergic reactions for people with a milk allergy or severe sensitivity. One of the top nine allergens that the FDA requires to be declared is milk, and improper labelling can be very risky. Why is this recall important? According to the Pennsylvania-based Weaver Nut Company, the recall is a preventative step to protect the public's health. The business is taking all necessary steps to ensure the safety of its products. Which chocolates are affected? Customers are advised to verify product lot codes and return or dispose of any impacted items. Throw away the items or return them to the store for a complete refund. Lot numbers 204206, 204207, 204208, 204209, 204212, 224225 are for Item 47518-Nonpareil, Semi-Sweet Chocolate (Christmas Seeds). Lot numbers 204214-RL, 204214, 204215, 224221, 224222, 224223, 135215, 135216, 135217, 135220, 135221, 145204, 145205-1, 145207-1, and 145210-1 are for Item D2645, Nonpareils, Semi-Sweet Chocolate (White Seeds), as per a report by Newsweek. FAQs What do I do if I have these chocolates? Check the lot number, and if it is recalled, do not eat it. Return it for a refund or dispose of it. Why is the recall so serious? Milk is a major allergen, and consuming it when allergic can result in serious or life-threatening reactions. Economic Times WhatsApp channel )
